ALEXANDRIA, Va., Sept. 10 -- United States Patent no. 12,409,208, issued on Sept. 9, was assigned to LBL BIOTECHNOLOGY INC. (Tainan, Taiwan).
"Treating tissue fibrosis with interleukin 24" was invented by Ming-Shi Chang (Tainan, Taiwan).
According to the abstract* released by the U.S. Patent & Trademark Office: "Methods of treating tissue fibrosis and/or injury and/or organ failure using an interleukin 24 (IL-24) protein or an interleukin 20 (IL-20) antagonist are provided."
The patent was filed on Oct. 28, 2020, under Application No. 17/771,930.
*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G...